Rocuronium Bromide Solution
Product Images NDC 71872-7036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (7036)

Pdp (7036)
This is a description of Rocuronium Bromide Injection, which is a sterile, non-pyrogenic solution available in a 50 mg/5 mL (10 mg/mL) 5 mL multiple dose vial for intravenous use only. The warning indicates that it may cause respiratory depression, so facilities for artificial respiration must be immediately available. The recommended storage temperature is 2-8°C (38-46°F) and the product should not be frozen. The product must be used within 60 days after removal from refrigeration to room temperature storage conditions (25°C/77°F). This product has been manufactured by X.Gan Pharmaceuticals, Inc. in Germany and is distributed by Medical Purchasing Solutions in Scottdale, AZ.*
FDA Label Image

Structural Formula (Rocuronium Bromide Injection 1)

FDA Label Image

Figure 1 (Rocuronium Bromide Injection 2)

FDA Label Image

Figure 2 (Rocuronium Bromide Injection 3)

FDA Label Image

Figure 3 (Rocuronium Bromide Injection 4)

FDA Label Image

5 mL Vial Label (Rocuronium Bromide Injection 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.